Correlation Between Armata Pharmaceuticals and Anebulo Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Armata Pharmaceuticals and Anebulo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Armata Pharmaceuticals and Anebulo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Armata Pharmaceuticals and Anebulo Pharmaceuticals, you can compare the effects of market volatilities on Armata Pharmaceuticals and Anebulo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Armata Pharmaceuticals with a short position of Anebulo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Armata Pharmaceuticals and Anebulo Pharmaceuticals.

Diversification Opportunities for Armata Pharmaceuticals and Anebulo Pharmaceuticals

0.64

Correlation Coefficient

Armata Pharmaceuticals  Anebulo Pharmaceuticals

Poor diversification

The 3 months correlation between Armata and Anebulo is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Armata Pharmaceuticals and Anebulo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anebulo Pharmaceuticals and Armata Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Armata Pharmaceuticals are associated (or correlated) with Anebulo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anebulo Pharmaceuticals has no effect on the direction of Armata Pharmaceuticals i.e., Armata Pharmaceuticals and Anebulo Pharmaceuticals go up and down completely randomly.

Pair Corralation between Armata Pharmaceuticals and Anebulo Pharmaceuticals

Given the investment horizon of 90 days Armata Pharmaceuticals is expected to generate 1.35 times less return on investment than Anebulo Pharmaceuticals. But when comparing it to its historical volatility, Armata Pharmaceuticals is 1.11 times less risky than Anebulo Pharmaceuticals. It trades about 0.14 of its potential returns per unit of risk. Anebulo Pharmaceuticals is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  111.00  in Anebulo Pharmaceuticals on May 6, 2025 and sell it today you would earn a total of  174.00  from holding Anebulo Pharmaceuticals or generate 156.76% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Armata Pharmaceuticals  vs.  Anebulo Pharmaceuticals

Armata Pharmaceuticals

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Armata Pharmaceuticals are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak primary indicators, Armata Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Anebulo Pharmaceuticals

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Anebulo Pharmaceuticals are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating technical and fundamental indicators, Anebulo Pharmaceuticals sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Armata Pharmaceuticals and Anebulo Pharmaceuticals

The main advantage of trading using opposite Armata Pharmaceuticals and Anebulo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Armata Pharmaceuticals position performs unexpectedly, Anebulo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anebulo Pharmaceuticals will offset losses from the drop in Anebulo Pharmaceuticals' long position.

The idea behind Armata Pharmaceuticals and Anebulo Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.